Legionnaire Disease Testing Market

Future Market Insights

Key Insight

The legionnaire disease testing market is projected to grow from USD 378.1 million in 2025 to USD 895.2 million by 2035, at a CAGR of 9.0%. Devices will dominate with a 39.4% market share, while urinary antigen test will lead the diagnostic test segment with a 45.7% share.

July 24, 2025

Anurag Sharma

342 Pages

Cite this Report

Legionnaire Disease Testing Market

https://www.futuremarketinsights.com/reports/legionnaire-disease-testing-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Albagaia Ltd
Aquacert Ltd
Becton
Bio-Rad Laboratories
BioMérieux SA
Dickinson
F. Hoffmann-La Roche Ag
Idexx Laboratories Inc.
Thermo Fischer Scientific Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Legionnaire Disease Testing Market

Key Players

Similar Industry Reports